886 participants
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-10-25
- Start Date:
- 2009-05-31
- Completion:
- 2010-07-31
Conditions
- Rheumatoid Arthritis
Interventions
- DRUG